Iterum Therapeutics SG&A Expense (Quarterly) Insights

Iterum Therapeutics PLC (ITRM)

1.595 +0.06 (+3.58%) USD | NASDAQ | May 01, 16:00

1.595 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	1.687M
September 30, 2023	1.833M
June 30, 2023	1.858M
March 31, 2023	2.098M
December 31, 2022	2.086M
September 30, 2022	2.681M
June 30, 2022	4.066M
March 31, 2022	3.933M
December 31, 2021	3.127M
September 30, 2021	3.029M
June 30, 2021	4.273M
March 31, 2021	3.396M
December 31, 2020	2.293M
September 30, 2020	2.398M

Date	Value
June 30, 2020	3.21M
March 31, 2020	3.151M
December 31, 2019	2.296M
September 30, 2019	2.933M
June 30, 2019	2.939M
March 31, 2019	3.116M
December 31, 2018	2.723M
September 30, 2018	2.657M
June 30, 2018	1.886M
March 31, 2018	1.515M
December 31, 2017	1.312M
September 30, 2017	1.021M
June 30, 2017	1.123M
March 31, 2017	1.008M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.687M

Minimum

Dec 2023

4.273M

Maximum

Jun 2021

2.805M

Average

2.933M

Median

Sep 2019

SG&A Expense (Quarterly) Benchmarks